Clinical Trial Update: Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing plasma and intracellular concentrations of raltegravir in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Changi General Hospital | Conditions: Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED